Benchmark indices experienced a negative close on Thursday, marked by volatile trade and profit booking. Analysts anticipate the Nifty to c...

Pharma stocks surged on Wednesday, supported by strong earnings and a weakening rupee, even as Sensex and Nifty traded lower. The Nifty Pha...

Even before the US-Israel-Iran war began, there was a sort of readjustment taking place in the mid-cap segment – a kind of valuation readju...

Despite the US and Iran failing to reach an agreement over the weekend, the street is not entirely in a bearish mood. Market breadth is not...

Sun Pharma shares rose sharply on Sunday after the company reported a 16% YoY rise in Q3 net profit to Rs 3,369 crore, supported by strong ...

Sun Pharma announced strong third quarter results. Sales rose 15% to Rs 15,469 crore and net profit climbed 16% to Rs 3,368 crore. Growth w...

Sun Pharma posted a strong Q3FY26 performance with net profit up 16% and revenue rising 13%. EBITDA surged 23% as margins expanded to 31.9%...

Sun Pharma reported a 19% YoY drop in Q4FY25 net profit to Rs 2,154 crore, while revenue rose 8% to Rs 12,959 crore. Final dividend set at ...

The company set February 6, 2025, as the record date for the dividend, payable by February 20, 2025. The company announced the dividend alo...

The revenues for the quarter grew nearly 10% while the net profit rose 16.5%. Both the domestic and US markets reported double-digit growth...

Coal India has announced an interim dividend of Rs 5.25 for the current fiscal, along with its third quarter financial results, and will go...

The drug maker had reported a profit of Rs 1,416.13 crore in the corresponding quarter last year.

The offer, for up to 75 lakh shares, will increase the promoter’s shareholding in Sun Pharma marginally to about 55% and cost roughly Rs 67...

The buyback price comes at a 16 per cent premium over Rs 752, the closing price of Sun Pharma on Thursday at BSE.

"As compared to international acquisitions done by Indian companies this is a fantastic acquisition for Sun, it is a domestic company."

Cipla - one of the oldest generic local pharma companies - became part of a select group of stocks which constituted the benchmark Sensex i...

Over two dozen companies, including heavyweight Reliance Industries (RIL), announced board meetings to consider interim dividend on Friday.